Emerald Advisers’s BioSpecifics Technologies Corp. BSTC Stock Holding History

Emerald Advisers’s Portfolio BSTC Stock Details BSTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-900	Closed	-$48K	–	367
2020 Q3	$48K	Buy	900 +500	+125%	+$30.9K	﹤0.01%	258
2020 Q2	$25K	Buy	+400	New	+$23.1K	﹤0.01%	257

Other funds holding BSTC

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Emerald Advisers's BSTC Position: Q4 2020 in Review

Emerald Advisers sold out of BioSpecifics Technologies Corp. (BSTC) in Q4 2020, closing a stake of 900 shares — an estimated $48K sold.

Emerald Advisers first reported a position in BSTC in Q2 2020 and held it in 2 quarters. The position peaked at $48K in Q3 2020. 1 fund tracked by Wall St. Rank holds BSTC as of Q4 2020.

Emerald Advisers reported no remaining BioSpecifics Technologies Corp. position as of Q4 2020 after selling out during the quarter.
Emerald Advisers sold 900 BioSpecifics Technologies Corp. shares in Q4 2020, an estimated $48K.
Emerald Advisers first reported a position in BioSpecifics Technologies Corp. in Q2 2020 and held it in 2 quarters.
Emerald Advisers's BioSpecifics Technologies Corp. position peaked at $48K in Q3 2020.
1 fund tracked by Wall St. Rank held BioSpecifics Technologies Corp. as of Q4 2020.

Based on Emerald Advisers's 13F filing for Q4 2020, filed 29 Jan 2021.